back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-01-29 12:26 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,670 vol |
50,670 | |
| Filed 2025-01-29 12:25 Tx date 2024-05-28 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-01-29 12:25 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-50,670 vol |
31,500 | |
| Filed 2024-12-20 17:26 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+82,170 vol |
82,170 | |
| Filed 2024-12-20 17:25 Tx date 2024-05-28 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-12-20 17:25 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$132,888
+117,600 vol $1.13 each |
317,600 | |
| Filed 2024-05-30 10:36 Tx date 2024-05-28 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$306,000
+200,000 vol $1.53 each |
200,000 | |
| Filed 2024-05-30 10:01 Tx date 2024-05-28 |
$ONC
Oncolytics Biotech Inc. |
Degois, Christophe
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|